GR3002981T3 - 1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl)-1h-imidazole - Google Patents

1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl)-1h-imidazole

Info

Publication number
GR3002981T3
GR3002981T3 GR91401109T GR910401109T GR3002981T3 GR 3002981 T3 GR3002981 T3 GR 3002981T3 GR 91401109 T GR91401109 T GR 91401109T GR 910401109 T GR910401109 T GR 910401109T GR 3002981 T3 GR3002981 T3 GR 3002981T3
Authority
GR
Greece
Prior art keywords
fluorophenyl
phenylmethyl
imidazole
useful
relates
Prior art date
Application number
GR91401109T
Other languages
English (en)
Inventor
Javier Bartroli
Manuel Anguita
Original Assignee
Uriach & Cia Sa J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uriach & Cia Sa J filed Critical Uriach & Cia Sa J
Publication of GR3002981T3 publication Critical patent/GR3002981T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GR91401109T 1988-07-28 1991-10-24 1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl)-1h-imidazole GR3002981T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88112239A EP0352352B1 (en) 1988-07-28 1988-07-28 1-[(2-Fluorophenyl)(4-fluorophenyl)phenylmethyl]-1H-imidazole

Publications (1)

Publication Number Publication Date
GR3002981T3 true GR3002981T3 (en) 1993-01-25

Family

ID=8199149

Family Applications (1)

Application Number Title Priority Date Filing Date
GR91401109T GR3002981T3 (en) 1988-07-28 1991-10-24 1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl)-1h-imidazole

Country Status (8)

Country Link
US (1) US5149707A (el)
EP (1) EP0352352B1 (el)
JP (1) JPH0625145B2 (el)
AT (1) ATE68486T1 (el)
CA (1) CA1327589C (el)
DE (1) DE3865675D1 (el)
GR (1) GR3002981T3 (el)
MX (1) MX9203166A (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2062941B1 (es) * 1993-03-15 1995-10-01 Uriach & Cia Sa J Nuevos derivados de azol activos por via oral.
US7531573B2 (en) * 1994-09-16 2009-05-12 Children's Medical Center Corporation Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
DE10035011A1 (de) 2000-07-19 2002-01-31 Bayer Ag Verfahren zur Herstellung von N,N`-Carbonyldiazolen und Azolidsalzen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1170188A (en) * 1967-09-15 1969-11-12 Bayer Ag N-trityl-imidazoles and salts and uses thereof
DE1670976B2 (de) * 1968-01-29 1976-07-22 N-trityl-imidazole
DE2213863C3 (de) * 1972-03-22 1982-05-13 Bayer Ag, 5090 Leverkusen Disubstituierte Triphenylmethylimidazole, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
US4755526A (en) * 1984-06-18 1988-07-05 Eli Lilly And Company Method of inhibiting aromatase

Also Published As

Publication number Publication date
JPH0625145B2 (ja) 1994-04-06
CA1327589C (en) 1994-03-08
EP0352352B1 (en) 1991-10-16
US5149707A (en) 1992-09-22
DE3865675D1 (de) 1991-11-21
ATE68486T1 (de) 1991-11-15
EP0352352A1 (en) 1990-01-31
JPH0248569A (ja) 1990-02-19
MX9203166A (es) 1992-07-01

Similar Documents

Publication Publication Date Title
MX9805628A (es) Imidazoles novedosos substituidos con cicloalquilo.
NL350005I2 (nl) Imidazoolverbindingen en biocidepreparaten, die deze bevatten.
TW218869B (el)
ZA945193B (en) Novel 1-substituted imidazole compounds as cytokine inhibitors.
EP0624159A4 (en) PYRIDYL SUBSTITUTED IMIDAZOLES.
EP0308135A3 (en) Ocular hypotensive agents
TW353067B (en) Isoquinolines
PH25681A (en) 3-substituted 1-(2-chlorothiazole-5-yl-methyl)-2-nitro-imino-1,3-diazacycloalkanes
CY2271B1 (en) 1.(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
DE3585873D1 (de) Vinylbenzyl-2,2,6,6-tetramethylpiperidine.
GR3002981T3 (en) 1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl)-1h-imidazole
NO944487L (no) 8-klor-11[1-[(5-metyl-3-pyridyl)metylÅ-4-piperidylidenÅ-6,11-dihydro-5H-benzo[5,6Åsyklohepta-[1,2-bÅpyridinfumarat
AR244690A1 (es) Compuestos con grupos triazol,tetrahidrofurano y fenilo,composicion fungicida que los contiene,procedimiento de preparacion de dichos compuestos y compuestos intermedios utilizados en los mismos.
AU549146B2 (en) 1-(1,3-benzodioxol-5-yl)-2-pyrrolidinone
NO880337L (no) Fremgangsmaate for fremstilling av 3-aryl-5-alkylthio-4h-1,2,4-triazoler.
EP0038003A3 (en) Antidepressant pyrrolylpiperidines
MXPA98008158A (es) Composicion anti-vih que contiene derivados de imidazol.
FI885108A0 (fi) Anordning foer att lokalisera den punkt, daer ett roerligt foeremaol oeverskrider en graens.
NO904186L (no) Imidazoler.
DE3863079D1 (de) 1-(2,4-difluorphenyl)-1-(1-fluorcyclopropyl)-2-(1,2,4-triazol-1-yl)-ethan-1-ol.
FI914426A (fi) Foerfarande foer framstaellning av 1-( (2s)-3-merkaptometyl-1-oxopropyl)l-prolin.
EP0257351A3 (en) 3-phenyl-3-(1h-1,2,4-triazol-1-ylmethyl)-5-substituted-2-methyl-isoxazolidines
ZA933961B (en) 1-(4-cyanophenylcarbamoyl)pyrazolines.
NL190929C (nl) 1-(Difenylmethyl)-4-(1,3-dioxolan-2-yl)-4-fenylbutylpiperazine, werkwijze voor de bereiding ervan alsmede farmaceutisch preparaat.
ZA914748B (en) Reconstituted timber.